| Test |
Code |
Sample Reqs |
Turnaround |
Special
Instructions
|
| D-Dimers (Fibrinogen Degradation Products) |
FDP |
C |
4 hrs |
4,18 |
| Dengue Virus DNA (PCR) |
DPCR |
B |
10 days981 |
|
| Dengue Virus Serology |
DENG |
B |
5 days |
9,14 |
| Deoxypyridinoline (DPD) – Serum |
SDPD |
B |
2 days |
|
| Deoxypyridinoline (DPD) – Urine |
DPD |
EMU |
4 days |
|
| Desmethylformamide |
DMF |
RU |
7-10 days955 |
|
| DHEA |
DHEX |
B |
7 days950 |
|
| DHEA – Urine (Dehydroepiandrosterone) |
UDHE |
CU |
10-15 days |
|
| DHEA Sulphate |
DHEA |
B |
4 hrs |
|
| Diabetic Profile 1 |
DIAB |
A, G |
8 hrs |
|
| Diabetic Profile 2 |
DIA2 |
A,G, RU |
2 days |
|
| Diazepam (Valium) |
DIAZ |
B |
10 days |
|
| Dibucaine Number |
DIBU |
B |
3 days |
|
| DiGeorge Syndrome (22q11 deletion) – karyotype + FISH |
KARY, FISH |
H |
12-17 days |
9 |
| DiGeorge Syndrome (22q11 deletion) – MLPA only |
MRML |
A |
10 days |
9 |
| Digitoxin |
DIGT |
B |
5 days |
|
| Digoxin |
DIGO |
B |
4 hrs |
|
Dihydropyrimidine Dehydrogenase deficiency (5-FU Toxicity) – common mutation (IVS14+1G>A)
| 5FU
| A
| 5 days
|
9 |
| Dihydrotestosterone |
DHT |
2xB |
5 days |
|
| Diphtheria Antibodies |
DIPH |
B |
5 days |
|
| Direct Antiglobulin Test (Coombs) |
COOM |
2xA |
1 day |
33 |
| Disopyramide |
DISO |
B |
5 days |
|
| Diuretic Screen – Urine |
URDI |
RU |
3 days |
|
| DL1 Biochemistry Profile |
DL1 |
B,G |
4 hrs |
|
| DL2 Biochemistry (24 Parameters) & Haematology Profile |
DL2 |
A, B, G |
4 hrs |
|
| DL3 Haematology Profile |
DL3 |
A |
4 hrs |
|
| DL4 Biochemistry (16 Parameters) & Haematology Profile |
DL4 |
A, B, G |
4 hrs |
|
| DL5 Biochemistry & Haematology Postal Profile |
DL5 |
A, B, G |
4 hrs |
|
| DL6 General Well Person Profile |
DL6 |
A, B, G |
4 hrs |
|
| DL7 Well Man Screen |
DL7 |
A, B, G |
4 hrs |
|
| DL8 Well Woman Screen |
DL8 |
A, B, G, TPV |
|
|
| DL9F Senior Female Profile 60+ |
DL9F |
A, 2xB, G, RU, RF |
|
4 |
| DL9M Senior Male Profile 60+ |
DL9M |
A, 2xB, G, RU, RF |
|
4 |
DL10 Cardiovascular Risk Profile 1
|
DL10 |
2xB |
3 days
|
|
DL11 Cardiovascular Risk Profile 2
|
DL11 |
3xB, C |
5 days
|
34 |
| DL12 7 STD Profile by PCR (7 PCR Tests from 1 Sample) |
DL12 |
FCRU or PCR Swab or TPV or Semen |
5 days934 |
|
| DNA (Double Stranded) Antibodies |
DNAA |
B |
2 days |
|
| DNA (Single Stranded) Antibodies |
DNAS |
B |
5 days |
|
DNA Extraction & Storage – 3 years (longer upon request)
|
XDNA
| 2xA
| 10 days
| |
| DNA fragmentation of semen |
SEXT |
Semen |
7 days954 |
1 |
| DOPA responsive dystonia – detection of mutation in a new patient |
GENE |
A |
4-6 weeks |
9,11 |
| Dog Components |
ZZ8 |
B |
3 days |
|
| Downs Risk Profile (1st trimester) |
DRP |
B, DRP form + image of scan |
3 days945 |
7,8 |
| Downs Risk Profile (2nd trimester) |
DRP |
B, DRP form |
3 days945 |
7,8 |
| Doxepin Level (Sinequan) |
DOXE |
B |
10 days |
|
| Doxycycline |
DOXY |
B |
10 days950 |
|
| Drugs Of Abuse – Hair (Chain Of Custody) |
DOAH |
J |
Contact laboratory941 |
|
| Drugs of Abuse Profile – Random Urine Sample/No Chain of Custody Plus Alcohol |
DOA3 |
RU |
2 days (5 days with GCMS confirmation)
|
|
| Drugs of Abuse Profile – Random Urine Sample/No Chain of Custody |
DOA |
RU |
2 days (5 days with GCMS confirmation)
|
|
| Drugs of Abuse Profile – With Chain of Custody |
DOAL |
RU/CoC Collection Containers |
2 days (5 days with GCMS confirmation)
946 |
1,2 |
| Drugs of Abuse Profile – Without Chain of Custody |
DOAN |
RU |
2 days (5 days with GCMS confirmation)
946 |
|
Duchenne Muscular Dystrophy – deletions/duplications
|
DMD | A
| 10 days
|
9 |
| DVT/Pre-travel screen |
DVT1 |
2xA, B |
5 days |
9 |
Test Information